Xeris Biopharma Holdings, Inc. (XERS) 8-K filings
- Ticker
- XERS (Nasdaq)
- SEC CIK
- 1867096
- Industry (SIC)
- 2834 Pharmaceutical Preparations
- All filings
- SEC EDGAR
Recent 8-Ks
| Accepted (ET) | Form | Items | Filing |
|---|---|---|---|
| 2026-11-05 07:12 | 8-K | 2.02 Earnings release | Details |
| 2026-11-02 08:05 | 8-K | 5.02 Executive or director change7.01 Reg FD disclosure | Details |
| 2026-10-14 07:08 | 8-K | 8.01 Other events | Details |